Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
CC transcript
SCIELE PHARMA, INC. (SCRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/10/2009 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2009 SC 13G/A Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend]
02/03/2009 SC 13G/A BARCLAYS GLOBAL INVESTORS NA reports a 0% stake in SCIELE PHARMA INC
10/09/2008 8-K Quarterly results
09/03/2008 8-K Entry into a Material Definitive Agreement, Departure of Directors or Principal Officers; Election of Directors; Appointment ...
Docs: "Agreement and Plan of Merger, among Shionogi & Co., Ltd., Tall Bridge, Inc. and Sciele Pharma, Inc.",
"Amended And Restated Employment Agreement, by and between Sciele Pharma, Inc., and Patrick Fourteau",
"Amended And Restated Employment Agreement, by and between Sciele Pharma, Inc., and Edward Schutter",
"Amended And Restated Employment Agreement, by and between Sciele Pharma, Inc., and Darrell Borne",
"Amended And Restated Employment Agreement, by and between Sciele Pharma, Inc., and Leslie Zacks",
"Amended And Restated Employment Agreement, by and between Sciele Pharma, Inc., and Larry Dillaha",
"Amended And Restated Employment Agreement, by and between Sciele Pharma, Inc., and Joseph Ciaffoni",
"SHIONOGI & CO., LTD. TO ACQUIRE SCIELE PHARMA, INC. SIGNIFICANTLY INCREASES SHIONOGI'S PRESENCE IN THE UNITED STATES",
"Form of Tender and Voting Agreement"
08/27/2008 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Employment Agreement between the Company and Joseph Ciaffoni"
07/31/2008 10-Q Quarterly Report for the period ended June 30, 2008
07/30/2008 8-K Quarterly results
Docs: "SCIELE PHARMA, INC. REPORTS RESULTS FOR THE SECOND QUARTER OF 2008 Second quarter 2008 financial results include:"
07/30/2008 TRN Sciele Pharma Inc. Q2 2008 Earnings Call Transcript
07/01/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "SCIELE PHARMA SIGNS AGREEMENT WITH ADDRENEX PHARMACEUTICALS TO DEVELOP AND MARKET ADX415 FOR THE TREATMENT OF HYPERTENSION"
05/23/2008 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Certificate of Elimination"
05/01/2008 10-Q Quarterly Report for the period ended March 31, 2008
04/30/2008 8-K Quarterly results
Docs: "SCIELE PHARMA, INC. REPORTS RESULTS FOR THE FIRST QUARTER OF 2008 First quarter 2008 financial results include:"
04/30/2008 TRN Sciele Pharma, Inc. Q1 2008 Earnings Call Transcript
04/28/2008 8-K Material Modifications to Rights of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "Sciele Pharma, Inc. Adopts $100 Million Share Repurchase Program ———————— Approves Redemption of Poison Pill"
03/14/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "SCIELE PHARMA ACQUIRES TWINJECT EPINEPHRINE AUTO-INJECTOR FROM VERUS PHARMACEUTICALS"
03/12/2008 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/11/2008 8-K Changes in Registrant.s Certifying Accountant, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Letter of BDO Seidman, LLP to the Securities and Exchange Commission",
"SCIELE PHARMA, INC. ANNOUNCES CHANGE OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMS"
03/07/2008 TRN Sciele Pharma Inc. Q4 2007 Earnings Call Transcript
02/29/2008 10-K Annual Report for the period ended December 31, 2007
02/29/2008 10-Q/A Quarterly Report for the period ended September 30, 2007 [amend]
02/29/2008 AR 2007 Annual Report
02/27/2008 8-K Quarterly results
Docs: "SCIELE PHARMA, INC. REPORTS RESULTS FOR FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2007",
"Letter from BDO Seidman, LLP to the Commission"
02/21/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "SCIELE AND ADDRENEX ANNOUNCE NDA SUBMISSION OF CLONIBID TO TREAT HYPERTENSION SCIELE PROVIDES UPDATE ON HEAD LICE ASPHYXIATION PRODUCT"
02/21/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "SCIELE PHARMA AND LIFECYCLE PHARMA ANNOUNCE U.S. MARKET LAUNCH OF FENOGLIDE™ ————————— NEW FORMULATION OF FENOFIBRATE IN 120-MG. AND 40-MG. DOSAGE STRENGTHS"
01/09/2008 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "SCIELE EXPECTS TO LAUNCH SIX PRODUCTS IN 2008; REAFFIRMS REVENUE AND EPS GUIDANCE FOR FULL-YEARS 2007 AND 2008"
01/04/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "SCIELE PHARMA ANNOUNCES FDA APPROVAL OF NEW SULAR® FORMULATION"
12/31/2007 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Employment Agreement between the Company and Patrick Fourteau",
"Employment Agreement between the Company and Edward Schutter",
"Employment Agreement between the Company and Darrell Borne",
"Employment Agreement between the Company and Leslie Zacks",
"Employment Agreement between the Company and Larry Dillaha"
12/07/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
12/05/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "EDWARD J. SCHUTTER APPOINTED TO PRESIDENT AND CHIEF OPERATING OFFICER OF SCIELE PHARMA, INC."
11/19/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "SCIELE SIGNS EXCLUSIVE AGREEMENT WITH NOVO NORDISK TO MARKET PRANDIN® AND PRANDIMET®"
11/05/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "SCIELE REPORTS THAT FDA EXTENDS PDUFA DATE ON NEW SULAR FORMULATION TO JANUARY 2, 2008"
10/31/2007 10-Q Quarterly Report for the period ended September 30, 2007
10/30/2007 8-K Quarterly results
Docs: "SCIELE PHARMA, INC. REPORTS REVENUES AND EARNINGS FOR THE THIRD QUARTER OF 2007"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy